- Country: United Kingdom
- Summary: Development and Manufacture of a Tranexamic Acid (Txa) Auto-Injector (Ai)
- GBT Ref No: 89123266
- Deadline: 06 Oct 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 709154452
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Project Description : The Ministry of Defence (MOD) are considering a requirement to develop a Tranexamic Acid Auto-Injector (TXA AI) containing 500mg/5ml formulation as soon as is technically possible, to reduce the need for clinical trials and gain UK MoD approval for off licence use. The UK MoD may subsequently seek an AI containing an improved formulation of TXA, by increasing concentration and reducing volume.
Please read the attached RFI and submit your response to the email address enclosed. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDevelopment and Manufacture of a Tranexamic Acid (Txa) Auto-Injector (Ai) - Uk Tender
The MINISTRY OF DEFENCE, a Government sector organization in United Kingdom, has announced a new tender for Development and Manufacture of a Tranexamic Acid (Txa) Auto-Injector (Ai). This tender is published on UkTender under GBT Ref No: 89123266 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-10-06.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
